Evidence map›Paper›PMID 31336653›Full record

ReviewInternational journal of molecular sciences2019

The Role of Leukotrienes as Potential Therapeutic Targets in Allergic Disorders.

Airi Jo-Watanabe, Toshiaki Okuno, Takehiko Yokomizo

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 79 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed, 2 pooled it
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 2 syntheses or guidelines pooled it, 144 citations in OpenAlex.

  1. Digital health tools in the management of allergic rhinitis: a systematic review.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2025
    Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Can Bisphenols Alter the Inflammation Process?Life (Basel, Switzerland) · 2025
    Review
  20. Mast cells are key mediators in the pulmonary inflammatory response to formaldehyde exposure.Toxicological sciences : an official journal of the Society of Toxicology · 2025
    Article

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Airi Jo-WatanabeDepartment of Biochemistry, Juntendo University School of Medicine, Tokyo 113-8421, Japan.
Toshiaki OkunoDepartment of Biochemistry, Juntendo University School of Medicine, Tokyo 113-8421, Japan.ORCID 0000-0003-0270-5744
Takehiko YokomizoDepartment of Biochemistry, Juntendo University School of Medicine, Tokyo 113-8421, Japan. yokomizo-tky@umin.ac.jp.ORCID 0000-0002-5219-1553
Juntendo University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leukotrienes (LTs) are lipid mediators that play pivotal roles in acute and chronic inflammation and allergic diseases. They exert their biological effects by binding to specific G-protein-coupled receptors. Each LT receptor subtype exhibits unique functions and expression patterns. LTs play roles in various allergic diseases, including asthma (neutrophilic asthma and aspirin-sensitive asthma), allergic rhinitis, atopic dermatitis, allergic conjunctivitis, and anaphylaxis. This review summarizes the biology of LTs and their receptors, recent developments in the area of anti-LT strategies (in settings such as ongoing clinical studies), and prospects for future therapeutic applications.

Indexed as

AnimalsBiomarkersDisease SusceptibilityGene Expression RegulationHumansHypersensitivityLeukotriene AntagonistsLeukotrienesMetabolic Networks and PathwaysMolecular Targeted TherapyReceptors, LeukotrieneSignal TransductionBiomarkersLeukotriene AntagonistsLeukotrienesReceptors, Leukotrieneallergic diseaseasthmaBLT1cysteinyl leukotrieneleukotrieneLTB4

Identifiers

PMID31336653
PMCPMC6679143
OpenAlexW2964027117

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.